Response rate - Globe Thesis

Keyword [Response rate] Result: 41 - 58 \| Page: 3 of 3
41.	The Efficacy Of Car-T Cell Therapy On Solid Tumors:A Meta-Analysis
42.	Development And Assessment Of A Novel Nomogram Based On NLR And PLR For Predicting Tumor Response Rate And Survival Rate Of Neoadjuvant Chemotherapy For Locally Advanced Gastric Cancer
43.	Survival Impact Of Remission Status After Up-front Chemotherapy On The Combined Treatment For Early Extra-node Nasal NK/T Cell Lymphoma
44.	A Meta-analysis Of The Efficacy Of CAR-T In The Treatment Of Relapsed/refractory DLBCL
45.	Observational Study Of Pyrotinib In The Treatment Of Her-2 Positive Advanced Breast Cancer
46.	The Effect Of Qingying Lidan Recipe Combined With UDCA On The Biochemical Response Rate Of Primary Biliary Cholangitis And The Experimental Study On TGF-β1 And Smad3
47.	What toxicologists and risk assessors think about hormesis: Results of a knowledge and opinion survey
48.	Multi-symptom management in hospice patients during end-of-life transition
49.	Efficacy And Safety Of Homoharringtonine For Treatment Of Acute Myeloid Leukemia: A Systematic Review And Meta-analysis
50.	Prognostic Significance Of CD200 On Adult Patients With Acute Myeloid Leukemia And Its Mechanism
51.	Efficacy And Influencing Factors Of Pertuzumab Combined With Trastuzumab In The Neoadjuvant Therapy Of HERT-2 Positive Breast Cancer
52.	Real-world Study Of PD-1/PD-L1 Immune Checkpoint Inhibitors In The Treatment Of Triple-negative Breast Cancer
53.	Comparative Survival,Efficacy,and Safety Of Demethylation Regimens With Other Regimens In The Treatment Of Myelodysplastic Syndrome:a Network Meta-analysis
54.	Efficacy And Safety Of Targeted BCMA CAR-T Therapy For Relapsed/refractory Multiple Myeloma
55.	Feasibility Of Collecting Infant And Young Child Feeding Data Through WeChat Self-administered Questionnaire
56.	Efficacy And Prognosis Analysis Of BTK Inhibitor-containing Combination Chemotherapy Regimen On PCNSL
57.	Analysis Of Efficacy And Prognosis Of Immune Checkpoint Inhibitors In Patient With Driver-negative Advanced Non-small Cell Lung Cancer After Previous Systemic Treatment Failure
58.	Clinical Prediction Model For The Treatment Of Ursodeoxycholic Acid In Primary Biliary Cholangitis
<<First <Prev Next> Last>> Jump to